A novel cryptic peptide derived from the rat neuropeptide FF precursor reverses antinociception and conditioned place preference induced by morphine

Peptides

Volumn 29, Issue 3, 2008, Pages 473-478

  Dylag, Tomasz ^a   Pachuta, Agnieszka ^b   Raoof, Hana ^a   Kotlinska, Jolanta ^b   Silberring, Jerzy ^a,c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Conditioned place preference; Morphine; NPFF precursor (85 99); Pain; Processing

Indexed keywords

ANTINOCICEPTIVE AGENT; CRYPTIC PEPTIDE; MORPHINE; NEUROPEPTIDE FF; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMINO ACID SEQUENCE; ANIMALS; CONDITIONING, OPERANT; MALE; MOLECULAR SEQUENCE DATA; MORPHINE; NOCICEPTORS; OLIGOPEPTIDES; PEPTIDES; RATS; RATS, WISTAR; SEQUENCE HOMOLOGY, AMINO ACID;

RATTUS;

EID: 39549102174     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.09.014     Document Type: Article

References (39)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., and Simmonet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 500 (1989) 169-176
2. Anko M.L., and Panula P. Functional modulation of human delta opioid receptor by neuropeptide FF. BMC Neuosci 6 (2005) 21
3. Arase K., Sakaguchi T., Takahashi M., Bray G.A., and Ling N. Effects of feeding behavior of rats of a cryptic peptide from the C-terminal end on prepro-growth hormone-releasing factor. Endocrinology 121 (1987) 1960-1965
4. Autelitano D.J., Rajic A., Smith A.I., Berndt M.C., Ilag L.L., and Vadas M. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug Discov Today 11 (2006) 306-314
5. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
6. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.M., et al. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides 22 (2001) 1085-1092
7. Bonnard E., Burlet-Schiltz O., Monsarrat B., Girard J.P., and Zajac J.M. Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue. Eur J Biochem 270 (2003) 4187-4199
8. Carr F.E., Fein H.G., Fisher C.U., Wessendorf M.W., and Smallbridge R.C. A cryptic peptide (160-169) of thyrotropin-releasing hormone prohormone demonstrates biological activity in vivo and in vitro. Endocrinology 131 (1982) 2653-2658
9. Carr F.E., Reid A.H., and Wessendorf M.W. A cryptic peptide from the preprothyrotropin-releasing hormone precursor stimulates thyrotropin gene expression. Endocrinology 133 (1993) 809-814
10. D'Este L., Casini A., Pontieri F.E., and Renda T.G. Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment. Brain Res 1083 (2006) 151-158
11. Deval E., Baron A., Linqueglia E., Mazarguil H., Zajac J.M., and Lazdunski M. Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability. Neuropharmacology 44 (2003) 662-671
12. Devillers J.P., Boisserie F., Laulin J.P., Larcher A., and Simmonet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res 700 (1995) 173-181
13. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
14. Jhamandas K., Milne B., Sutak M., Gouarderes C., Zajac J.M., and Yang H.Y. Facilitation of spinal morphine analgesia in normal and morphine tolerant animals by neuropeptide SF and related peptides. Peptides 27 (2006) 953-963
15. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci Lett 115 (1991) 307-312
16. Kavaliers M., and Yang H.Y. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides 10 (1989) 741-745
17. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., et al. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 133 (2001) 138-144
18. Kotlinska J., Pachuta A., Dylag T., and Silberring J. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Neuropeptides 41 (2007) 51-58
19. Malin D.H., Lake J.R., Fowler D.E., Hammond M.V., Brown S.L., Leyva J.E., et al. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11 (1991) 277-280
20. Marchand S., Betourne A., Marty V., Daumas S., Halley H., Lassalle J.M., et al. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 27 (2006) 964-972
21. Molloy S.S., Bresnahan P.A., Leppla S.H., Klimpel K.R., and Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267 (1992) 16396-16402
22. Nakayama K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327 (1997) 625-635
23. Ng J.H., and Ilaq L.L. Cryptic protein fragments as an emerging source of peptide drugs. IDrugs 9 (2006) 343-346
24. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848 (1999) 191-196
25. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (2005), Elsevier, Amsterdam
26. Raffa R.B., Kim A., Rice K.C., de Costa B.R., Codd E.E., and Rothman R.B. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors. Peptides 15 (1994) 401-404
27. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12 (1992) 129-138
28. Rothman R.B., Brady L.S., Xu H., and Long J.B. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain. Peptides 14 (1993) 1271-1277
29. Roumy M., Gouarderes C., Mazarguil H., and Zajac J.M. Are neuropeptides FF and SF neurotransmitters in the rat?. Biochem Biophys Res Commun 275 (2000) 821-824
30. Roumy M., Lorenzo C., Mazères S., Bouchet S., Zajac J.M., and Mollereau C. Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J Biol Chem 282 (2007) 8332-8342
31. Southey B.R., Rodriguez-Zas S.L., and Sweedler J.V. Prediction of neuropeptide prohormone cleavages with application to RFamides. Peptides 27 (2006) 1087-1098
32. Stinus L., Allard M., Gold L., and Simmonet G. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides 16 (1995) 1235-1241
33. Tang J., Yang H.Y., and Costa E. Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity. Proc Natl Acad Sci USA 81 (1984) 5002-5005
34. Ueki N., Someya K., Matsuo Y., Wakamatsu K., and Mukai H. Cryptides: functional cryptic peptides hidden in protein structures. Biopolymers 88 (2007) 190-198
35. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55 (1999) 804-811
36. Yang H.Y., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1985) 7757-7761
37. Yang H.Y., and Iadarola M.J. Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides 27 (2006) 943-952
38. Yang H.Y., and Martin R.M. Isolation and characterization of a neuropeptide FF-like peptide from brain and spinal cord of rat. Abstr Soc Neurosci 21 (1995) 760
39. Yudin Y.K., Tamarova Z.A., and Krishtal O.A. Peripherally applied neuropeptide SF is equally algogenic in wild type and ASIC3-/- mice. Neurosci Res 55 (2006) 421-425